Walden Group Healthcare M&A Blog

FDA Bans Sales of Transvaginal Mesh

04/23/2019
The FDA has ordered the two remaining medical device companies, Boston Scientific and Coloplast, selling surgical mesh for the repair of pelvic organ prolapse to stop all sales and distribution in the US. The FDA said the two companies did not demonstrate a reasonable assurance of safety and effectiveness of these devices in their premarket...
Read More
Breakthroughs in Developing Artificial Hearts

04/23/2019
Scientists in Israel have printed the world’s first 3D heart made of human tissue and biological molecules. Using tissues from the patient to make a personalized “ink,” a specialized printer was used to produce a working, pumping human heart complete with blood vessels. Because the engineered heart is made of the patient’s own tissues,...
Read More
GE is Shrinking Even Further – Selling Its Biopharma Business to CEO’s Former Company

04/23/2019
General Electric is selling its biopharma business to Danaher Corp. for $21.4b. The deal complements Danaher's current biologics workflow solutions. GE’s biopharma business includes process chromatography hardware and consumables, cell culture media, single-use technologies, development instrumentation and consumables, and related services. GE...
Read More
Rapid Growth for Gene Therapy

04/23/2019
Large pharmaceutical and diagnostic players companies have been acquiring emerging gene and cell therapy companies with promising drug pipelines or drug approvals, some with limited revenue. In March 2019, Thermo Fisher Scientific agreed to pay $1.7b to acquire Brammer Bio, which offers pre-clinical and analytical development, process...
Read More
Catalent to Acquire Paragon Bioservices for $1.2b

04/15/2019
Catalent, Inc., a $2.46b provider of delivery technologies for drugs, biologics, and consumer and animal health products, is buying Paragon Bioservices, Inc., a developer of viral vectors for gene therapies. The deal Complements Catalent's biologics business. Paragon engages in the production and purification of therapeutic proteins, monoclonal...
Read More